Bluejay Diagnostics (BJDX) Stock Statistics & Valuation Metrics

Bluejay Diagnostics has a market cap or net worth of $1.39M. The enterprise value is -$849.88K.

Bluejay Diagnostics has 1,814,133 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bluejay Diagnostics’s return on equity (ROE) is -1.35 and return on invested capital (ROIC) is -120.29%.

The current PE Ratio of Bluejay Diagnostics is ―. Bluejay Diagnostics’s PEG ratio is 0.00275.

In the last 12 months, Bluejay Diagnostics had revenue of 0.00 and earned -7.72M in profits. Earnings per share was -42.08.

In the last 12 months, operating cash flow was -6.34M and capital expenditures -1.12K, giving a free cash flow of -6.34M billion.

Bluejay Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―

Bluejay Diagnostics upcoming earnings date is Apr 16, 2025, Before Open (Confirmed).

Bluejay Diagnostics as a current ratio of 6.05, with Debt / Equity ratio of 3.13%

In the past 12 months, Bluejay Diagnostics has paid 0.00 in taxes.

Bluejay Diagnostics EV to EBITDA ratio is 0.48, with an EV/FCF ratio of 0.39.

Bluejay Diagnostics has $3.08M in cash and marketable securities with $142.99K in debt, giving a net cash position of $2.94M billion.

Gross margin is -16.56%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Bluejay Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―